The first ever individual patient meta-analysis of three phase III randomized trials that assessed the impact of prolongation of short-term ADT with radiotherapy.

Results will be presented at the ASTRO 2021 Annual Meeting in Chicago, IL.

This represents the first individual patient meta-analysis of every single phase III trial that has been published assessing the benefit of short-term ADT to radiotherapy that reported metastasis and survival outcomes.

Results will be presented at the ASTRO 2021 Annual Meeting in Chicago, IL.

This is the first individual patient meta-analysis of randomized phase III trials that assessed the prolongation of short-term to long-term adjuvant ADT.

Results will be presented at the ASTRO 2021 Annual Meeting in Chicago, IL.